{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:33:31Z","timestamp":1780626811560,"version":"3.54.1"},"reference-count":28,"publisher":"Consilium Medicum","issue":"3","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. To assess effectiveness and safety of biological therapy in patients with severe asthma during 5 yr follow-up.\r\nMaterials and methods. We recruited 129 adult outpatients (29% males) aged 18\u201381 yrs with severe asthma were followed up during 5 yrs and were examined for every 3\u20136 months. Eighty five patients were treated by conventional therapy (ICS\/LABA \u00b1 tiotropium, montelukast, OCS) only and 44 pts additionally received biologicals (\u043emalizumab \u2013 9 pts, \u043cepolizumab \u2013 8 pts, benralizumab \u2013 11 pts, dupilumab \u2013 16 pts). Pulmonary function tests were measured by dry spirometer (2120, Vitalograph Ltd., UK). Eosinophil count in blood was assessed by automatic haemoanalyser. Fraction of exhaled nitric oxide was measured by a chemiluminescence analyzer (LR4100; Logan Research, UK). Asthma control and quality of life were assessed by using Russian versions of ACQ-5 and SGRQ.\r\nResults. The use of biologicals led to a more significant reduction of exacerbations and OCS use, improvement of lung function, asthma control and quality of life, decrease of eosinophil and fraction of exhaled nitric oxide than conventional therapy of severe asthma (p0.05). Systemic side effects were not registered, frequency of local adverse reactions (edema, hyperemia and itching at injection site) was 14%.\r\nConclusion. Long-term use of biologicals added to conventional therapy in patients with severe asthma is characterized by high effectiveness and favorable safety profile.<\/jats:p>","DOI":"10.26442\/00403660.2024.03.202626","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T19:05:29Z","timestamp":1713294329000},"page":"240-245","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness and safety of biological therapy in patients with severe asthma in a real clinical practice"],"prefix":"10.26442","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-4336","authenticated-orcid":false,"given":"Galina R.","family":"Sergeeva","sequence":"additional","affiliation":[{"name":"Mechnikov North-Western State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8574-6869","authenticated-orcid":false,"given":"Alexander V.","family":"Emelyanov","sequence":"additional","affiliation":[{"name":"Mechnikov North-Western State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"ref1","unstructured":"Global Initiative for Asthma. NHLB\/WHO Workshop Report. National Heart Lung Blood Institute, updated 2022. Available at: 2022 GINA Main Report \u2013 Global Initiative for Asthma \u2013 GINA (ginasthma.org). Accessed: 14.03.2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00588-2019"},{"key":"ref4","unstructured":"\u0411\u0440\u043e\u043d\u0445\u0438\u0430\u043b\u044c\u043d\u0430\u044f \u0430\u0441\u0442\u043c\u0430. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0435 \u0440\u0435\u0441\u043f\u0438\u0440\u0430\u0442\u043e\u0440\u043d\u043e\u0435 \u043e\u0431\u0449\u0435\u0441\u0442\u0432\u043e, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0430\u0441\u0441\u043e\u0446\u0438\u0430\u0446\u0438\u044f \u0430\u043b\u043b\u0435\u0440\u0433\u043e\u043b\u043e\u0433\u043e\u0432 \u0438 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0438\u043c\u043c\u0443\u043d\u043e\u043b\u043e\u0433\u043e\u0432, \u0421\u043e\u044e\u0437 \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u043e\u0432 \u0420\u043e\u0441\u0441\u0438\u0438. 2021 [Bronkhial'naia astma. Klinicheskie rekomendatsii. Rossiiskoe respiratornoe obshchestvo, Rossiiskaia assotsiatsiia allergologov i klinicheskikh immunologov, Soiuz pediatrov Rossii. 2021 (in Russian)]."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18565\/therapy.2022.1.133-141"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.9120-11ST"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/all.14221"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200312-1651OC"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.06.014"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00042-9"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0702-4"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31324-1"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31322-8"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703501"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804093"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00352-0"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.09.033"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.07.058"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00322-2"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.015414"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.196"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S354062"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2019.PA4261"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.10.053"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207630"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/109579\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/109579\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T08:58:23Z","timestamp":1733216303000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/109579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,16]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2024.03.202626","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,16]]}}}